X

Buy Products not in the Philippines

Galleon.PH - Discover, Share, Buy!
Hematology-Oncology Therapy, 3rd Edition
Hematology-Oncology Therapy, 3rd Edition

Hematology-Oncology Therapy, 3rd Edition

Product ID : 42572599
5 out of 5 stars


Galleon Product ID 42572599
Shipping Weight 1.11 lbs
I think this is wrong?
Model
Manufacturer McGraw-Hill Education / Medical
Shipping Dimension 0 x 0 x 0 inches
I think this is wrong?
-
No price yet.
Price not yet available.

Pay with

About Hematology-Oncology Therapy, 3rd Edition

Product Description The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care--Updated with the Latest Treatment Regimens Hematology-Oncology Therapy, Third Edition is an up-to-date, comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniform manner. The unique tabular design allows you to instantly locate and implement the proper treatment regimen. Supported by the latest practice guidelines, peer-reviewed literature, and the opinion of experts, Hematology-Oncology Therapy integrates extensive information that is critical to both office- and hospital-based practice of hematology and oncology. Conveniently divided into three sections: Oncology; Supportive Care, Drug Preparation, Complications, and Screening; Selected Hematologic Diseases Updated to include the latest regimens From the Publisher Michael Boyiadzis, MD, Associate Professor of Medicine, Department of Medicine, Division of Hematology/Oncology, UPMC Cancer Pavilion.   Antonio Tito Fojo, MD, PhD, Professor of Medicine, Columbia University Medical Center Director, Neuroendocrine Cancers Co-Director, Adrenal Center Co-Director, Columbia/James J. Peters VA Hospital Cancer Center David R. Kohler, PharmD, Pharmacy Department, National Institutes of Health About the Author McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide Michael Boyiadzis, MD, Associate Professor of Medicine, Department of Medicine, Division of Hematology/Oncology, UPMC Cancer Pavilion.   Antonio Tito Fojo, MD, PhD, Professor of Medicine, Columbia University Medical Center Director, Neuroendocrine Cancers Co-Director, Adrenal Center Co-Director, Columbia/James J. Peters VA Hospital Cancer Center David R. Kohler, PharmD, Pharmacy Department, National Institutes of Health